UBS Group’s Magellan Health Services MGLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
– Sell
-400
Closed -$22K – 10450
2014
Q3
$22K Buy
+400
New +$23K ﹤0.01% 7919
2014
Q2
– Sell
-300
Closed -$18K – 10969
2014
Q1
$18K Buy
+300
New +$17.9K ﹤0.01% 8258

UBS Group's MGLN Position: Q1 2022 in Review

UBS Group sold out of Magellan Health Services (MGLN) in Q1 2022, closing a stake of 365,865 shares — an estimated $34.8M sold.

UBS Group first reported a position in MGLN in Q2 2013 and held it in 35 quarters. The position peaked at $34.9M in Q3 2021. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.

  • UBS Group reported no remaining Magellan Health Services position as of Q1 2022 after selling out during the quarter.
  • UBS Group sold 365,865 Magellan Health Services shares in Q1 2022, an estimated $34.8M.
  • UBS Group first reported a position in Magellan Health Services in Q2 2013 and held it in 35 quarters.
  • UBS Group's Magellan Health Services position peaked at $34.9M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Magellan Health Services as of Q1 2022.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.